This trial is active, not recruiting.

Condition limb-girdle muscular dystrophy
Sponsor Nationwide Children's Hospital
Collaborator National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Start date June 2005
Trial size 500 participants
Trial identifier NCT00457912, IRB05-00101, NIH Grant U54AR050733


The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this study, the investigators will perform a muscle biopsy and DNA testing in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will be extended to the family of the study subject in order to better understand true genetic defect.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - any subject with clinical diagnosis of LGMD - must visit Columbus Children's Hospital for 2-day study visit - muscle biopsy tissue must be available; either from previous biopsy, affected relative, or willing to have biopsy at Columbus Children's Exclusion Criteria: - diagnosis of a neuromuscular disorder other than LGMD - unable to provide muscle tissue from previous or current biopsy - incapable of giving consent and not having a legal guardian willing or able to do so

Additional Information

Official title Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Principal investigator Jerry R. Mendell, M.D.
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by Nationwide Children's Hospital.